nach oben

Current Cardiology Reports

Erschienen in:

05.07.2022 | Global Cardiovascular Health (L Sperling and D Gaita, Section Editors)

Health Disparities Across the Continuum of ASCVD Risk

verfasst von: Ankita Devareddy, Ashish Sarraju, Fatima Rodriguez

Erschienen in: Current Cardiology Reports | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of the Review

Despite marked progress in cardiovascular disease management in the last several decades, there remain significant, persistent disparities in cardiovascular health in historically marginalized racial and ethnic groups. Here, we outline current state of health disparities in cardiovascular disease, discuss the interplay between social determinants of health, structural racism, and cardiovascular outcomes, and highlight strategies to address these issues.

Recent Findings

Across the continuum of atherosclerotic cardiovascular disease (ASCVD) prevention, there remain significant disparities in outcomes including morbidity and mortality by race, ethnicity, and socioeconomic status (SES). These disparities begin early in childhood (primordial prevention) and continue with a higher prevalence of cardiovascular risk factors (primary prevention), and in the uptake of evidence-based therapies (secondary prevention). These disparities are driven by social determinants of health and structural racism that disproportionately disadvantage historically marginalized populations.

Summary

Structural racism and social determinants of health contribute to significant disparities in cardiovascular morbidity and mortality.

Centers for Disease Control and Prevention. About underlying cause of death, 1999–2018.https://wonder-cdc-gov.laneproxy.stanford.edu/ucd-icd10.html. Accessed 8 Feb 2022.

•• Churchwell K, Elkind MSV, Benjamin RM, Carson AP, Chang EK, Lawrence W, Mills A, Odom TM, Rodriguez CJ, Rodriguez F, Sanchez E, Sharrief AZ, Sims M, Williams O, American Heart Association. Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association. Circulation. 2020;142(24):e454-e468. https://doi.org/10.1161/CIR.0000000000000936. Epub 2020 Nov 10. The American Heart Association released a Call to Action regarding the effects of structural racism on health disparities with recommendations on how to mitigate these adverse effects.

Sheiham A. Closing the gap in a generation: health equity through action on the social determinants of health. A report of the WHO Commission on Social Determinants of Health (CSDH) 2008. Community Dent Health. 2009;26(1):2–3.

Trivedi AN, Nsa W, Hausmann LR, Lee JS, Ma A, Bratzler DW, Mor MK, Baus K, Larbi F, Fine MJ. Quality and equity of care in U.S. hospitals. N Engl J Med. 2014;371(24):2298–308. https://doi.org/10.1056/NEJMsa1405003.

Graham G. Disparities in cardiovascular disease risk in the United States. Curr Cardiol Rev. 2015;11(3):238–45. https://doi.org/10.2174/1573403x11666141122220003.CrossRefPubMedPubMedCentral

Lurie N, Fremont A, Jain AK, Taylor SL, McLaughlin R, Peterson E, Kong BW, Ferguson TB Jr. Racial and ethnic disparities in care: the perspectives of cardiologists. Circulation. 2005;111(10):1264–9. https://doi.org/10.1161/01.CIR.0000157738.12783.71.CrossRefPubMed

Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347(20):1585–92. https://doi.org/10.1056/NEJMsa012979.CrossRefPubMed

• Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD, American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613. https://doi.org/10.1161/CIRCULATIONAHA.109.192703. Epub 2010 Jan 20. The American Heart Association outlines ideal healthy behaviors, including goals for blood pressure, body mass index, and lipid levels, and sets a goal of reducing cardiovascular and stroke mortality by 20%.

Climie R, Fuster V, Empana JP. Health Literacy and Primordial Prevention in Childhood-An Opportunity to Reduce the Burden of Cardiovascular Disease. JAMA Cardiol. 2020;5(12):1323–4. https://doi.org/10.1001/jamacardio.2020.2864.CrossRefPubMed

10.

McGill HC Jr, McMahan CA. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol. 1998;82(10B):30T-36T. https://doi.org/10.1016/s0002-9149(98)00720-6.

11.

Theodore RF, Broadbent J, Nagin D, Ambler A, Hogan S, Ramrakha S, Cutfield W, Williams MJ, Harrington H, Moffitt TE, Caspi A, Milne B, Poulton R. Childhood to Early-Midlife Systolic Blood Pressure Trajectories: Early-Life Predictors, Effect Modifiers, and Adult Cardiovascular Outcomes. Hypertension. 2015;66(6):1108–15. https://doi.org/10.1161/HYPERTENSIONAHA.115.05831. Epub 2015 Oct 5.CrossRefPubMed

12.

Creanga AA, Bateman BT, Kuklina EV, Callaghan WM. Racial and ethnic disparities in severe maternal morbidity: a multistate analysis, 2008–2010. Am J Obstet Gynecol. 2014;210(5):435.e1-8. https://doi.org/10.1016/j.ajog.2013.11.039. Epub 2013 Dec 1.CrossRef

13.

Howell EA, Egorova NN, Balbierz A, Zeitlin J, Hebert PL. Site of delivery contribution to black-white severe maternal morbidity disparity. Am J Obstet Gynecol. 2016;215(2):143–52. https://doi.org/10.1016/j.ajog.2016.05.007. Epub 2016 May 12.CrossRefPubMedPubMedCentral

14.

Nahum Sacks K, Friger M, Shoham-Vardi I, Spiegel E, Sergienko R, Landau D, Sheiner E. Prenatal exposure to preeclampsia as an independent risk factor for long-term cardiovascular morbidity of the offspring. Pregnancy Hypertens. 2018;13:181–6. https://doi.org/10.1016/j.preghy.2018.06.013. Epub 2018 Jun 18.CrossRefPubMed

15.

Pathirana MM, Lassi ZS, Roberts CT, Andraweera PH. Cardiovascular risk factors in offspring exposed to gestational diabetes mellitus in utero: systematic review and meta-analysis. J Dev Orig Health Dis. 2020;11(6):599–616. https://doi.org/10.1017/S2040174419000850. Epub 2020 Jan 6.CrossRefPubMed

16.

Alexander DS, Huber LR, Piper CR, Tanner AE. The association between recreational parks, facilities and childhood obesity: a cross-sectional study of the 2007 National Survey of Children’s Health. J Epidemiol Community Health. 2013;67(5):427–31. https://doi.org/10.1136/jech-2012-201301. Epub 2013 Jan 30.CrossRefPubMed

17.

Gordon-Larsen P, Nelson MC, Page P, Popkin BM. Inequality in the built environment underlies key health disparities in physical activity and obesity. Pediatrics. 2006;117(2):417–24. https://doi.org/10.1542/peds.2005-0058.CrossRefPubMed

18.

Sallis JF, Floyd MF, Rodríguez DA, Saelens BE. Role of built environments in physical activity, obesity, and cardiovascular disease. Circulation. 2012;125(5):729–37. https://doi.org/10.1161/CIRCULATIONAHA.110.969022.CrossRefPubMedPubMedCentral

19.

Testa A, Jackson DB, Semenza DC, Vaughn MG. Food deserts and cardiovascular health among young adults. Public Health Nutr. 2021;24(1):117–24. https://doi.org/10.1017/S1368980020001536. Epub 2020 Jul 9.CrossRefPubMed

20.

Sarrazin MS, Campbell ME, Richardson KK, Rosenthal GE. Racial segregation and disparities in health care delivery: conceptual model and empirical assessment. Health Serv Res. 2009;44(4):1424–44. https://doi.org/10.1111/j.1475-6773.2009.00977.x. Epub 2009 May 7.CrossRefPubMed

21.

Gordon C, Purciel-Hill M, Ghai NR, Kaufman L, Graham R, Van Wye G. Measuring food deserts in New York City’s low-income neighborhoods. Health Place. 2011;17(2):696–700. https://doi.org/10.1016/j.healthplace.2010.12.012. Epub 2011 Jan 6.CrossRefPubMed

22.

McKenzie TL, Moody JS, Carlson JA, Lopez NV, Elder JP. Neighborhood Income Matters: Disparities in Community Recreation Facilities, Amenities, and Programs. J Park Recreat Admi. 2013;31(4):12–22.

23.

Katz SF, Rodriguez F, Knowles JW. Health disparities in cardiometabolic risk among Black and Hispanic youth in the United States. Am J Prev Cardiol. 2021;23(6): 100175. https://doi.org/10.1016/j.ajpc.2021.100175.CrossRef

24.

Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–77. https://doi.org/10.1161/01.cir.67.5.968.CrossRefPubMed

25.

Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. Sedentary Behavior, Exercise, and Cardiovascular Health. Circ Res. 2019;124(5):799–815. https://doi.org/10.1161/CIRCRESAHA.118.312669.CrossRefPubMed

26.

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76.

27.

Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity Among Adults and Youth: United States, 2015–2016. NCHS Data Brief. 2017;288:1–8.

28.

Winkleby MA, Robinson TN, Sundquist J, Kraemer HC. Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. JAMA. 1999;281(11):1006–13. https://doi.org/10.1001/jama.281.11.1006.CrossRefPubMed

29.

Brady TM, Fivush B, Parekh RS, Flynn JT. Racial differences among children with primary hypertension. Pediatrics. 2010;126(5):931–7. https://doi.org/10.1542/peds.2009-2972. Epub 2010 Oct 18.CrossRefPubMed

30.

Rogers R, Eagle TF, Sheetz A, Woodward A, Leibowitz R, Song M, Sylvester R, Corriveau N, Kline-Rogers E, Jiang Q, Jackson EA, Eagle KA. The Relationship between Childhood Obesity, Low Socioeconomic Status, and Race/Ethnicity: Lessons from Massachusetts. Child Obes. 2015;11(6):691–5. https://doi.org/10.1089/chi.2015.0029. Epub 2015 Nov 12.CrossRefPubMedPubMedCentral

31.

Schröder SL, Richter M, Schröder J, Frantz S, Fink A. Socioeconomic inequalities in access to treatment for coronary heart disease: A systematic review. Int J Cardiol. 2016;15(219):70–8. https://doi.org/10.1016/j.ijcard.2016.05.066. Epub 2016 May 14.CrossRef

32.

Howard G, Prineas R, Moy C, Cushman M, Kellum M, Temple E, Graham A, Howard V. Racial and geographic differences in awareness, treatment, and control of hypertension: the Reasons for Geographic And Racial Differences in Stroke study. Stroke. 2006;37(5):1171–8. https://doi.org/10.1161/01.STR.0000217222.09978.ce. Epub 2006 Mar 23.CrossRefPubMed

33.

Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988–1994 and 1999–2010. Ann Intern Med. 2014;160(8):517–25. https://doi.org/10.7326/M13-2411.CrossRefPubMedPubMedCentral

34.

Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005;111(10):1233–41. https://doi.org/10.1161/01.CIR.0000158136.76824.04.CrossRefPubMed

35.

Mitchell BD, Stern MP, Haffner SM, Hazuda HP, Patterson JK. Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. Am J Epidemiol. 1990;131(3):423–33. https://doi.org/10.1093/oxfordjournals.aje.a115517.

36.

Watanabe JH, Kazerooni R, Bounthavong M. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study. J Manag Care Pharm. 2014;20(1):43–50. https://doi.org/10.18553/jmcp.2014.20.1.43.CrossRefPubMed

37.

Williams RA. Cardiovascular disease in African American women: a health care disparities issue. J Natl Med Assoc. 2009;101(6):536–40. https://doi.org/10.1016/s0027-9684(15)30938-x.CrossRefPubMed

38.

Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, Zaman A, Fryer AA, Kadam U, Chew-Graham CA, Mamas MA. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2):e003497. https://doi.org/10.1161/CIRCOUTCOMES.116.003497. Epub 2017 Feb 22.

39.

Graham GN, Jones PG, Chan PS, Arnold SV, Krumholz HM, Spertus JA. Racial Disparities in Patient Characteristics and Survival After Acute Myocardial Infarction. JAMA Netw Open. 2018;1(7):e184240. https://doi.org/10.1001/jamanetworkopen.2018.4240.

40.

Tucker MJ, Berg CJ, Callaghan WM, Hsia J. The Black-White disparity in pregnancy-related mortality from 5 conditions: differences in prevalence and case-fatality rates. Am J Public Health. 2007;97(2):247–51. https://doi.org/10.2105/AJPH.2005.072975. Epub 2006 Dec 28.CrossRefPubMedPubMedCentral

41.

Gyamfi-Bannerman C, Pandita A, Miller EC, Boehme AK, Wright JD, Siddiq Z, D’Alton ME, Friedman AM. Preeclampsia outcomes at delivery and race. J Matern Fetal Neonatal Med. 2020;33(21):3619–26. https://doi.org/10.1080/14767058.2019.1581522. Epub 2019 Feb 20.CrossRefPubMed

42.

Leng B, Jin Y, Li G, Chen L, Jin N. Socioeconomic status and hypertension: a meta-analysis. J Hypertens. 2015;33(2):221–9. https://doi.org/10.1097/HJH.0000000000000428.CrossRefPubMed

43.

Biswas S, Andrianopoulos N, Duffy SJ, Lefkovits J, Brennan A, Walton A, Chan W, Noaman S, Shaw JA, Ajani A, Clark DJ, Freeman M, Hiew C, Oqueli E, Reid CM, Stub D. Impact of Socioeconomic Status on Clinical Outcomes in Patients With ST-Segment-Elevation Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2019;12(1):e004979. https://doi.org/10.1161/CIRCOUTCOMES.118.004979.CrossRefPubMed

44.

Ohm J, Skoglund PH, Häbel H, Sundström J, Hambraeus K, Jernberg T, Svensson P. Association of Socioeconomic Status With Risk Factor Target Achievements and Use of Secondary Prevention After Myocardial Infarction. JAMA Netw Open. 2021;4(3): e211129. https://doi.org/10.1001/jamanetworkopen.2021.1129.CrossRefPubMedPubMedCentral

45.

Gerber Y, Goldbourt U, Drory Y, Israel Study Group on First Acute Myocardial Infarction. Interaction between income and education in predicting long-term survival after acute myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2008;15(5):526–32. https://doi.org/10.1097/HJR.0b013e328304feac.

46.

Hyun KK, Brieger D, Woodward M, Richtering S, Redfern J. The effect of socioeconomic disadvantage on prescription of guideline-recommended medications for patients with acute coronary syndrome: systematic review and meta-analysis. Int J Equity Health. 2017;16(1):162. https://doi.org/10.1186/s12939-017-0658-z.CrossRefPubMedPubMedCentral

47.

Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2019;4(3):206–13. https://doi.org/10.1001/jamacardio.2018.4936.CrossRefPubMedPubMedCentral

48.

Vaccarino V, Rathore SS, Wenger NK, Frederick PD, Abramson JL, Barron HV, Manhapra A, Mallik S, Krumholz HM, National Registry of Myocardial Infarction Investigators. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005;353(7):671–82. https://doi.org/10.1056/NEJMsa032214.

49.

Vatcheva KP, Aparicio V, Araya A, Gonzalez E, Laing ST. Statin Prescription for Patients With Atherosclerotic Cardiovascular Disease from National Survey Data. Am J Cardiol. 2019;124(1):1–7. https://doi.org/10.1016/j.amjcard.2019.03.048. Epub 2019 Apr 8.CrossRefPubMed

50.

Foraker RE, Rose KM, Whitsel EA, Suchindran CM, Wood JL, Rosamond WD. Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance. BMC Public Health. 2010;21(10):632. https://doi.org/10.1186/1471-2458-10-632.CrossRef

51.

Rao SV, Schulman KA, Curtis LH, Gersh BJ, Jollis JG. Socioeconomic status and outcome following acute myocardial infarction in elderly patients. Arch Intern Med. 2004;164(10):1128–33. https://doi.org/10.1001/archinte.164.10.1128.CrossRefPubMed

52.

Lauffenburger JC, Robinson JG, Oramasionwu C, Fang G. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction. Circulation. 2014;129(7):754–63. https://doi.org/10.1161/CIRCULATIONAHA.113.002658. Epub 2013 Dec 10.CrossRefPubMed

53.

Zhang Y, Baik SH, Chang CC, Kaplan CM, Lave JR. Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors. Am Heart J. 2012;164(3):425-433.e4. https://doi.org/10.1016/j.ahj.2012.05.021. Epub 2012 Aug 3.CrossRefPubMedPubMedCentral

54.

Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR. Race and trust in the health care system. Public Health Rep. 2003;118(4):358–65. https://doi.org/10.1093/phr/118.4.358.

55.

Scharff DP, Mathews KJ, Jackson P, Hoffsuemmer J, Martin E, Edwards D. More than Tuskegee: understanding mistrust about research participation. J Health Care Poor Underserved. 2010;21(3):879–97. https://doi.org/10.1353/hpu.0.0323.CrossRefPubMedPubMedCentral

56.

van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians’ perceptions of patients. Soc Sci Med. 2000;50(6):813–28. https://doi.org/10.1016/s0277-9536(99)00338-x.CrossRefPubMed

57.

Bernheim SM, Ross JS, Krumholz HM, Bradley EH. Influence of patients' socioeconomic status on clinical management decisions: a qualitative study. Ann Fam Med. 2008;6(1):53–9. https://doi.org/10.1370/afm.749.

58.

• Essien UR, Dusetzina SB, Gellad WF. A Policy Prescription for Reducing Health Disparities-Achieving Pharmacoequity. JAMA. 2021;326(18):1793-1794. https://doi.org/10.1001/jama.2021.17764. This review outlines a three pronged approach to reducing health disparities via pharmacoequity and increasing access to prescription medications.

59.

Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH, Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365(22):2088–97. https://doi.org/10.1056/NEJMsa1107913. Epub 2011 Nov 14.

60.

López L, Wilper AP, Cervantes MC, Betancourt JR, Green AR. Racial and sex differences in emergency department triage assessment and test ordering for chest pain, 1997–2006. Acad Emerg Med. 2010;17(8):801–8. https://doi.org/10.1111/j.1553-2712.2010.00823.x.CrossRefPubMed

61.

Venkat A, Hoekstra J, Lindsell C, Prall D, Hollander JE, Pollack CV Jr, Diercks D, Kirk JD, Tiffany B, Peacock F, Storrow AB, Gibler WB. The impact of race on the acute management of chest pain. Acad Emerg Med. 2003;10(11):1199–208. https://doi.org/10.1111/j.1553-2712.2003.tb00604.x.CrossRefPubMed

62.

Mukhopadhyay A, D’Angelo R, Senser E, Whelan K, Wee CC, Mukamal KJ. Racial and insurance disparities among patients presenting with chest pain in the US: 2009–2015. Am J Emerg Med. 2020;38(7):1373–6. https://doi.org/10.1016/j.ajem.2019.11.018. Epub 2019 Nov 19.CrossRefPubMed

63.

Takakuwa KM, Shofer FS, Hollander JE. The influence of race and gender on time to initial electrocardiogram for patients with chest pain. Acad Emerg Med. 2006;13(8):867–72. https://doi.org/10.1197/j.aem.2006.03.566. Epub 2006 Jun 26.CrossRefPubMed

64.

Sabatine MS, Blake GJ, Drazner MH, Morrow DA, Scirica BM, Murphy SA, McCabe CH, Weintraub WS, Gibson CM, Cannon CP. Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment. Circulation. 2005;111(10):1217–24. https://doi.org/10.1161/01.CIR.0000157733.50479.B9.CrossRefPubMed

65.

Barnhart JM, Fang J, Alderman MH. Differential use of coronary revascularization and hospital mortality following acute myocardial infarction. Arch Intern Med. 2003;163(4):461–6. https://doi.org/10.1001/archinte.163.4.461.CrossRefPubMed

66.

Cram P, Bayman L, Popescu I, Vaughan-Sarrazin MS. Racial disparities in revascularization rates among patients with similar insurance coverage. J Natl Med Assoc. 2009;101(11):1132–9. https://doi.org/10.1016/s0027-9684(15)31109-3.CrossRefPubMed

67.

Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dubé R, Taleghani CK, Burke JE, Williams S, Eisenberg JM, Escarce JJ. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340(8):618-26. https://doi.org/10.1056/NEJM199902253400806. Erratum in: N Engl J Med. 1999;340(14):1130.

68.

Skinner J, Chandra A, Staiger D, Lee J, McClellan M. Mortality after acute myocardial infarction in hospitals that disproportionately treat black patients. Circulation. 2005;112(17):2634–41. https://doi.org/10.1161/CIRCULATIONAHA.105.543231.CrossRefPubMedPubMedCentral

69.

Bradley EH, Herrin J, Wang Y, McNamara RL, Webster TR, Magid DJ, Blaney M, Peterson ED, Canto JG, Pollack CV Jr, Krumholz HM. Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA. 2004;292(13):1563–72. https://doi.org/10.1001/jama.292.13.1563.CrossRefPubMed

70.

Cooke CR, Nallamothu B, Kahn JM, Birkmeyer JD, Iwashyna TJ. Race and timeliness of transfer for revascularization in patients with acute myocardial infarction. Med Care. 2011;49(7):662–7. https://doi.org/10.1097/MLR.0b013e31821d98b2.CrossRefPubMedPubMedCentral

71.

Johnson PA, Lee TH, Cook EF, Rouan GW, Goldman L. Effect of race on the presentation and management of patients with acute chest pain. Ann Intern Med. 1993;118(8):593–601. https://doi.org/10.7326/0003-4819-118-8-199304150-00004.CrossRefPubMed

72.

Werner RM, Asch DA, Polsky D. Racial profiling: the unintended consequences of coronary artery bypass graft report cards. Circulation. 2005;111(10):1257–63. https://doi.org/10.1161/01.CIR.0000157729.59754.09.CrossRefPubMed

73.

Yeo KK, Li Z, Amsterdam E. Clinical characteristics and 30-day mortality among Caucasians, Hispanics, Asians, And African-Americans in the 2003 California coronary artery bypass graft surgery outcomes reporting program. Am J Cardiol. 2007;100(1):59–63. https://doi.org/10.1016/j.amjcard.2007.02.053. Epub 2007 May 11.CrossRefPubMed

74.

Chaudhry SI, Khan RF, Chen J, Dharmarajan K, Dodson JA, Masoudi FA, Wang Y, Krumholz HM. National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010. J Am Heart Assoc. 2014;3(5):e001197. https://doi.org/10.1161/JAHA.114.001197. Erratum in: J Am Heart Assoc. 2014;3(6):e000522.

75.

Schneiderman N, Chirinos DA, Avilés-Santa ML, Heiss G. Challenges in preventing heart disease in hispanics: early lessons learned from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Prog Cardiovasc Dis. 2014;57(3):253–61. https://doi.org/10.1016/j.pcad.2014.08.004. Epub 2014 Aug 13.

76.

Stringhini S, Carmeli C, Jokela M, Avendaño M, Muennig P, Guida F, Ricceri F, d'Errico A, Barros H, Bochud M, Chadeau-Hyam M, Clavel-Chapelon F, Costa G, Delpierre C, Fraga S, Goldberg M, Giles GG, Krogh V, Kelly-Irving M, Layte R, Lasserre AM, Marmot MG, Preisig M, Shipley MJ, Vollenweider P, Zins M, Kawachi I, Steptoe A, Mackenbach JP, Vineis P, Kivimäki M, LIFEPATH consortium. Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women. Lancet. 2017;389(10075):1229–1237. https://doi.org/10.1016/S0140-6736(16)32380-7. Epub 2017 Feb 1. Erratum in: Lancet. 2017;389(10075):1194.

77.

Barakat K, Stevenson S, Wilkinson P, Suliman A, Ranjadayalan K, Timmis AD. Socioeconomic differentials in recurrent ischaemia and mortality after acute myocardial infarction. Heart. 2001;85(4):390–4. https://doi.org/10.1136/heart.85.4.390.CrossRefPubMedPubMedCentral

78.

Ohm J, Skoglund PH, Discacciati A, Sundström J, Hambraeus K, Jernberg T, Svensson P. Socioeconomic status predicts second cardiovascular event in 29,226 survivors of a first myocardial infarction. Eur J Prev Cardiol. 2018;25(9):985–93. https://doi.org/10.1177/2047487318766646. Epub 2018 Apr 17.CrossRefPubMed

79.

Ochiai E, Kigenyi T, Sondik E, Pronk N, Kleinman DV, Blakey C, Fromknecht CQ, Heffernan M, Brewer KH. Healthy People 2030 Leading Health Indicators and Overall Health and Well-being Measures: Opportunities to Assess and Improve the Health and Well-being of the Nation. J Public Health Manag Pract. 2021;27(Suppl 6):S235-S241. https://doi.org/10.1097/PHH.0000000000001424.

80.

Michos ED, Van Spall HGC. Increasing representation and diversity in cardiovascular clinical trial populations. Nat Rev Cardiol. 2021;18(8):537–8. https://doi.org/10.1038/s41569-021-00583-8.CrossRefPubMed

81.

Sarraju A, Valencia A, Knowles JW, Maron DJ, Rodriguez F. Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials. Circulation. 2021;143(24):2409–11. https://doi.org/10.1161/CIRCULATIONAHA.120.050034. Epub 2021 Jun 14.CrossRefPubMedPubMedCentral

82.

Sarraju A, Maron DJ, Rodriguez F. Under-Reporting and Under-Representation of Racial/Ethnic Minorities in Major Atrial Fibrillation Clinical Trials. JACC Clin Electrophysiol. 2020;6(6):739–41. https://doi.org/10.1016/j.jacep.2020.03.001.CrossRefPubMedPubMedCentral

83.

Cohen JJ, Gabriel BA, Terrell C. The case for diversity in the health care workforce. Health Aff (Millwood). 2002;21(5):90–102. https://doi.org/10.1377/hlthaff.21.5.90.

Titel: Health Disparities Across the Continuum of ASCVD Risk
verfasst von: Ankita Devareddy
Ashish Sarraju
Fatima Rodriguez
Publikationsdatum: 05.07.2022
Verlag: Springer US
Erschienen in: Current Cardiology Reports / Ausgabe 9/2022
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-022-01736-y

Neu im Fachgebiet Kardiologie

19.04.2024 | Vorhofflimmern | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Health Disparities Across the Continuum of ASCVD Risk

Abstract

Purpose of the Review

Recent Findings

Summary

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose of the Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2022

Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes

Racial Disparities in Cardiovascular Risk and Cardiovascular Care in Women

Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022

Tricuspid Valve Percutaneous Therapies

Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations

Emerging Genotype–Phenotype Associations in Dilated Cardiomyopathy

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie